Track Your Zepbound Protocol

Zepbound is the FDA-approved weight loss version of tirzepatide, the same active ingredient as Mounjaro.

Generic Name

Tirzepatide

Manufacturer

Eli Lilly

Mechanism

Dual GIP/GLP-1 receptor agonist

Approved For

Chronic weight management

Typical Weight Loss

20-22%

Dosing Frequency

Once weekly injection

Why Track with DoseCurve?

✓Log every injection with visual body map
✓Track weight with dose-colored charts
✓See your estimated blood levels in real-time
✓Compare progress to clinical trial data
✓Smart reminders based on your schedule

This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication.